International Consortium of Mohs Surgery Launches to Support Global Collaboration in Skin Cancer Care
Key Takeaways
- The International Consortium of Mohs Surgery (ICMS) has launched as a global professional association focused on Mohs micrographic surgery and cutaneous oncology.
- Founding documents were signed September 12, 2026, in London, with the organization aiming to connect Mohs surgeons, trainees, and allied professionals internationally through education, research, and professional collaboration.
- ICMS is also seeking pharmaceutical, biotechnology, and device industry partnerships to support training, research, and other initiatives, with individual membership applications expected to open in October and corporate membership in November.
The International Consortium of Mohs Surgery (ICMS) has officially launched as a global professional association focused on advancing Mohs micrographic surgery and cutaneous oncology through education, research, collaboration, and professional exchange.
ICMS leadership signed the organization’s founding documents in London on September 12, 2026. According to the organization, the consortium was established to bring together Mohs surgeons, trainees, and allied professionals across regions where Mohs surgery is practiced.
ICMS Seeks Global Collaboration in Mohs Surgery and Cutaneous Oncology
In addition to connecting clinicians internationally, ICMS plans to develop education, training, fellowship, and research initiatives. The organization is inviting pharmaceutical, biotechnology, and medical device companies involved in dermatologic oncology to participate in its early programs, including potential real-world data and outcomes research in nonmelanoma skin cancer.
“Skin cancer is one of the most common cancers in the world, and no single organization—physician-led or otherwise—can address that burden alone,” Ashley Wysong, MD, MS, founding president of ICMS, said in the announcement.
“We built ICMS to be a genuine partner to industry: a place where pharmaceutical and device companies can engage directly with the surgeons treating this disease across every region where Mohs surgery is practiced, and help us close gaps in training, research, and patient access worldwide,” Wysong added.
ICMS positions the organization as a centralized international forum for industry engagement with Mohs surgeons and other skin cancer specialists, who have traditionally participated through national and regional professional societies.
The organization expects to open formal membership applications for individual surgeons and allied professionals this month, followed by corporate membership applications in November.